Pfizer Reports $491M Deal With DOJ Over Rapamune Marketing
Pfizer Inc. revealed Thursday that it has agreed to pay $491 million to settle a U.S. Department of Justice investigation into the marketing by Pfizer unit Wyeth Pharmaceuticals Inc. of kidney...To view the full article, register now.
Already a subscriber? Click here to view full article